1-s2.0-S0920996418303633-main.pdf (406.91 kB)
Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis
journal contribution
posted on 2023-03-30, 17:29 authored by Courtney L. M. Nelson, Hayley M. Amsbaugh, James L. Reilly, Cherise RosenCherise Rosen, Robert MarvinRobert Marvin, Michael RagozzinoMichael Ragozzino, Jeffrey R. Bishop, John A. Sweeney, S. Kristian HillThis study evaluated the ability to flexibly shift cognitive set and to consistently maintain a new response preference using the Penn Conditional Exclusion Test (PCET). The relationship of performance errors with catechol-O-methyltransferase (COMT) rs4680 (Val158Met) genotype (Met carriers vs. Val homozygotes) on test performance before and after antipsychotic treatment in 32 first episode psychosis (FEP) patients was examined. After treatment, patients demonstrated a mixture of beneficial and adverse cognitive outcomes that varied in relation to COMT genotype. Met carriers showed decreased perseverative and regressive errors, reflecting improved cognitive flexibility and enhanced stability of behavioral preferences, respectively. In contrast, Val homozygotes exhibited an increase in regressive errors after treatment. These findings suggest that Val homozygotes may be vulnerable to adverse effects of antipsychotic medication on cognitive processes that maintain consistent adaptive response preferences, an ability linked to the striatum in rodent models.
Funding
Oculomotor & Spacital Cognition Deficits in Schizophreni | Funder: National Institutes of Health (National Institute of Mental Health) | Grant ID: R01MH062134
Enhancing Cognition in Schizophrenia | Funder: National Institutes of Health (National Institute of Mental Health) | Grant ID: K23MH072767
Bipolar & Schizophrenia Consortium for Parsing Intermediate Phenotypes | Funder: National Institutes of Health (National Institute of Mental Health) | Grant ID: R01MH077862
Schizophrenia Pharmacogenetics: Cognition And Syptom Response To Antipsychotics | Funder: National Institutes of Health (National Institute of Mental Health) | Grant ID: K08MH083888
History
Citation
Nelson, C. L. M., Amsbaugh, H. M., Reilly, J. L., Rosen, C., Marvin, R. W., Ragozzino, M. E., Bishop, J. R., Sweeney, J. A.Hill, S. K. (2018). Beneficial and adverse effects of antipsychotic medication on cognitive flexibility are related to COMT genotype in first episode psychosis. Schizophrenia Research, 202, 212-216. https://doi.org/10.1016/j.schres.2018.06.029Publisher
ElsevierLanguage
- en
issn
0920-9964Usage metrics
Categories
No categories selectedKeywords
COMTPCETPsychosisAntipsychotic3214 Pharmacology and Pharmaceutical Sciences32 Biomedical and Clinical SciencesBrain DisordersMental HealthClinical Trials and Supportive ActivitiesClinical ResearchMental healthAdultAntipsychotic AgentsBipolar DisorderCatechol O-MethyltransferaseCognitionDepressive Disorder, MajorExecutive FunctionFemaleHeterozygoteHumansMalePharmacogenomic VariantsPsychotic DisordersSchizophreniaSchizophrenic PsychologyPsychiatry3202 Clinical sciencesMedical and Health SciencesPsychology and Cognitive Sciences